Bookmark

Add to MyYahoo RSS

Hemophilia News

News on Hemophilia continually updated from thousands of sources around the net.

Wednesday | Hispanic Business

Nine Chicago Nonprofits To Receive Almost $400,000 In Donations And...

Starlight Children's Foundation Midwest, dedicated to improving the lives and health of seriously ill children and their families, was the first place winner and will receive a .

Comment?

Related Topix: Health

Tue Jul 22, 2014

GlobalNews

Patient safety concerns raised after nursing staff reduction at SJ hospital

Patients with bleeding disorders such as hemophilia say reductions to nursing staff at the Saint John Regional Hospital are putting their health at risk.

Comment?

Related Topix: Nursing, Medicine, Health

GlobalNews

Why Ontario is moving to ban paying people for their blood

Ontario plans to join Quebec in banning payments to people for their blood and blood plasma, following the opening of two paid plasma clinics in Toronto.

Comment?

Related Topix: Ontario (Ontario, CA), North America, Canada, World News, Health

Hispanic Business

Baxter Declares Quarterly Dividend

As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Comment?

Related Topix: Health, Infectious Diseases, Medicine

Sat Jul 19, 2014

Washington Times

JAMA opinion piece calls for ending lifetime ban on blood donation by gay men

Gay marriage laws and court rulings against sexual-orientation discrimination are all signs that it's time for the federal government to change its blood-donor policy for gay and bisexual men, authors said in a commentary released Saturday.

Comment?

Related Topix: Gay/Lesbian, Brown University, Health, Opinion

Fri Jul 18, 2014

P&T Community

New Coagulation Factor Shows Promise as Once-Weekly Prophylaxis for Hemophilia B

Positive results have been reported from a phase III trial comparing a prophylactic regimen of BeneFIX coagulation factor IX, recombinant 100 IU/kg once-weekly with on-demand treatment in subjects with moderately severe to severe hemophilia B .

Comment?

Related Topix: Health

Benzinga

Biotech Enters Reporting Season With Large Caps Central To Sector Performance

Biotech stock stocks enter their earnings season with investors increasingly interested in the long-term outlook for product pipelines, although large-cap growth stocks remain central to the sectors performance, an analyst said Friday.

Comment?

Related Topix: Financial Markets, Biotech, Biogen Idec, Health, Medicine, Gilead Sciences, Healthcare Industry, Startups, Celgene

Thu Jul 17, 2014

Reuters

UPDATE 1-Medical products boost Baxter's sales

Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly earnings and revenue, helped by surging sales in its medical products division.

Comment?

Related Topix: Medicine, Baxter International, Medical Equipment, Healthcare Industry, Biotech, Science / Technology, Health

Science Blog

Plant-based research improves hemophilia treatment

Hemophilia is a rare but potentially dangerous disease. People with the condition produce very low levels of clotting factor, the proteins in blood that stop bleeding and help begin the healing process.

Comment?

Related Topix: Health, Biology, Science, Biochemistry

Business Journal

Arcade pharmacy to add home health nursing services

Cottril's Pharmacy Inc. filed an application with the state Department of Health to become licensed as a home health services agency.

Comment?

Related Topix: Nursing, Medicine, Health

Wed Jul 16, 2014

Seeking Alpha

Positive top-line results for BeneFIX

In a Phase 3 clinical tria l comparing Pfizer's BeneFIX Coagulation Factor IX as a treatment for patients with moderately severe-to-severe hemophilia B to on-demand treatment, the once-weekly therapy achieved its primary endpoint of a statistically significant reduction in the annualized bleeding rate versus on-demand.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Health

TheStreet.com

Why Pfizer (PFE) Stock Is Up Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Mozilla, Health, TheStreet

Reuters

Pfizer says clotting drug's once-weekly dose reduces bleeding rate

Pfizer Inc said a once-weekly dose of its drug, already approved for on-demand treatment of a blood clotting disorder, reduced bleeding rates in patients in a late-stage study.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Health

BioSpace

Pfizer Inc. Hemophilia B Treatment Regimen Meets Endpoint In Phase 3 Trial

Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA Once-Weekly Prophylaxis For Hemophilia B - See more at: http://press.pfizer.com/press-release/pfizer-announces-positive-top-line-results-phase-3-study-nonacog-alfa-benefix-once-wee#sthash.YaBu8KgQ.dpuf Once-Weekly Prophylaxis Treatment with BeneFIXA Significantly Reduced ... (more)

Comment?

Related Topix: Health, Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Healthcare Law, Law, Foldrx Pharmaceuticals

Wall Street Journal

Pfizer Hemophilia B Treatment Regimen Meets Endpoint

Pfizer Inc. said a regimen for treating patients with hemophilia B met the primary endpoint of its Phase 3 trial.

Comment?

Related Topix: Health, Pfizer, Biotech, Medicine, Healthcare Industry

Fri Jul 11, 2014

Business Wire

Research and Markets: Global Blood Plasma Market Report: 2014 Edition

With the swift changes and advancement in biomedical/healthcare technology, the healthcare/pharmaceutical/therapeutic industry is becoming ever more competitive.

Comment?

Related Topix: Health

Wed Jul 09, 2014

Freshnews

Baxter Acquires AesRx, LLC, Including Its Investigational Sickle Cell Disease Treatment

Baxter International Inc. today announced the acquisition of AesRx, LLC, a private U.S. biopharmaceutical company focused on orphan drug targets, including the development and commercialization of Aes-103, an investigational prophylactic treatment for sickle cell disease .

Comment?

Related Topix: Medicine, Baxter International, Medical Equipment, Healthcare Industry, Food and Drug Administration, Virginia Commonwealth University, Health

Freshnews

OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive...

OPKO Health, Inc. today announced that the European Committee for Orphan Medicinal Products gave a positive opinion recommending the approval of orphan drug designation for OPKO's long-acting version of clotting Factor VIIa for the treatment of bleeding episodes in patients with hemophilia A or B with inhibitors to Factor VIII or Factor IX and ... (more)

Comment?

Related Topix: Biotech, Opko Health, Health, Marketing, Opinion

Contract Pharma Breaking News

Baxter Acquires AesRx

Baxter International has acquired AesRx, LLC , a private U.S. biopharma company focused on orphan drug targets.

Comment?

Related Topix: Medicine, Baxter International, E.Factor, Medical Equipment, Healthcare Industry, Health

Mon Jul 07, 2014

BioSpace

FDA Approves Novo Nordisk A/S's NovoSeven?? RT To Treat Glanzmann's...

Glanzmann's Thrombasthenia is a rare genetic bleeding disorder with limited treatment options.

Comment?

Related Topix: Food and Drug Administration, Genetics, Medicine, Hematology, Health

•••
•••
•••
•••
•••
•••
•••
•••